Recorded August 18, 2020 | On-Demand Webinar
This session will discuss the varying authorities FDA has to combat fraudulent products including warning letters, seizures, injunctions, and criminal prosecutions.
This session was recorded as part of FDLI’s virtual course, "COVID-19: Introduction to FDA’s Existing Legal Authorities and Emerging Issues" in August 2020.